SCHEMBL9747613

SCHEMBL9747613

CC(C)c1ccccc1COc1cccnc1N

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.56
MAPK14 Q16539 1/20 0.56
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAPT P10636 1/20 0.46
NISCH Q9Y2I1 1/20 0.44
P2RX3 P56373 2/20 0.43
P2RX2 Q9UBL9 2/20 0.43
DCPS Q96C86 1/20 0.42
MET P08581 1/20 0.38
SGMS2 Q8NHU3 3/20 0.37
AKT1 P31749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9125515 0.80 LTA4H (0.61) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL9746554 0.80 LTA4H (0.61) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL6080009 0.80 NPC1 (0.61) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL23005062 0.78 NISCH (0.41) SMN1; SMN2MAPTNISCHP2RX3P2RX2
SCHEMBL488757 0.77 LTA4H (0.61) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL6079375 0.77 LTA4H (0.61) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL15452368 0.77 LTA4H (0.53) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL488805 0.77 LTA4H (0.61) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL10560687 0.77 LTA4H (0.56) LTA4HMAPK14NPC1RAB9AHTT
SCHEMBL10678765 0.77 LTA4H (0.56) LTA4HMAPK14NPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0204285-B1 IMIDAZOHETEROCYCLIC COMPOUNDS PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-01-15 EP disclosed
US-4725601-A Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-02-16 US disclosed
EP-0204285-A1 Imidazoheterocyclic compounds processes for preparation thereof and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-12-10 EP disclosed